ArticleCancer research2020

Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer.

P Jake Slavish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.